Stathmin is expressed by the proliferating hepatocytes during liver regeneration
- PMID: 16695988
- PMCID: PMC407931
- DOI: 10.1136/mp.48.2.m88
Stathmin is expressed by the proliferating hepatocytes during liver regeneration
Abstract
Aim-To determine the liver cell populations that express the phylogenetically conserved cytosolic protein stathmin during liver regeneration.Methods-Double immunostaining for stathmin and the Ki67 antigen was performed on sections of formaldehyde fixed, paraffin wax embedded tissues from 31 liver specimens. These included a variety of disease conditions characterised by some degree of hepatocyte regeneration. Quantitative western blot analysis was performed on 22 of these specimens.Results-Variable amounts of stathmin protein were detected by western blotting in all of the specimens examined. Stathmin was not detected in three cases of histologically normal liver. On immunostaining, stathmin was demonstrated in a proportion of hepatocytes as well as lymphoid inflammatory cells and other tissue elements. In all cases most of these stathmin positive cells showed nuclear positivity for the Ki67 antigen.Conclusions-Stathmin is expressed by proliferating hepatocytes but not by resting hepatocytes. Thus, it is likely that the protein has a function important to cell proliferation as opposed to cell differentiation.
Similar articles
-
Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages.Lab Invest. 1995 Jan;72(1):100-13. Lab Invest. 1995. PMID: 7837783
-
Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde.Am J Pathol. 1992 Feb;140(2):513-20. Am J Pathol. 1992. PMID: 1346735 Free PMC article.
-
Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression.Hepatology. 1992 Apr;15(4):707-13. doi: 10.1002/hep.1840150426. Hepatology. 1992. PMID: 1372584
-
Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.Endocr Pathol. 2008 Summer;19(2):97-103. doi: 10.1007/s12022-008-9028-0. Endocr Pathol. 2008. PMID: 18461287
-
Stathmin 1: a novel therapeutic target for anticancer activity.Expert Rev Anticancer Ther. 2008 Sep;8(9):1461-70. doi: 10.1586/14737140.8.9.1461. Expert Rev Anticancer Ther. 2008. PMID: 18759697 Review.
Cited by
-
SHP2 inhibition enhances Yes-associated protein-mediated liver regeneration in murine partial hepatectomy models.JCI Insight. 2022 Aug 8;7(15):e159930. doi: 10.1172/jci.insight.159930. JCI Insight. 2022. PMID: 35763355 Free PMC article.
-
Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma.Sci Rep. 2016 Dec 9;6:38756. doi: 10.1038/srep38756. Sci Rep. 2016. PMID: 27934948 Free PMC article.
-
Stathmin is involved in S100A4-mediated regulation of cell cycle progression.Clin Exp Metastasis. 1999;17(10):865-71. doi: 10.1023/a:1006778804532. Clin Exp Metastasis. 1999. PMID: 11089885
-
Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.Biochim Biophys Acta. 2015 Jan;1852(1):104-19. doi: 10.1016/j.bbadis.2014.10.012. Epub 2014 Oct 27. Biochim Biophys Acta. 2015. PMID: 25445540 Free PMC article.
-
Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling.Tumour Biol. 2015 Jan;36(1):399-408. doi: 10.1007/s13277-014-2629-y. Epub 2014 Sep 30. Tumour Biol. 2015. PMID: 25266798
References
LinkOut - more resources
Full Text Sources